METASTATIC COLORECTAL CANCER (CRC)
Clinical trials for METASTATIC COLORECTAL CANCER (CRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (CRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets multiple KRAS mutations in advanced cancers
Disease control Recruiting nowThis early-stage trial is testing a new drug called BBO-11818 in people with advanced cancers that have specific KRAS gene mutations. The study aims to find a safe dose and see if the drug can shrink tumors in cancers like lung, pancreatic, and colorectal cancer. Participants wil…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for advanced colon cancer patients in houston trial
Disease control Recruiting nowThis study is testing whether adding a drug called fruquintinib to standard chemotherapy works better as a first treatment for advanced colorectal cancer that cannot be removed by surgery. Fifty patients will receive the combination treatment in monthly cycles, with the goal of c…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo trial offers hope for advanced colon cancer patients
Disease control Recruiting nowThis study compares two different chemotherapy combinations for people newly diagnosed with advanced colorectal cancer that has spread. Researchers want to see if a newer combination called NALIRIFOX works better and is safer than the standard FOLFOX treatment, when both are give…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New cancer drug trial aims to outperform current standard treatment
Disease control Recruiting nowThis study compares two different drug combinations for people newly diagnosed with advanced colorectal cancer that has spread. About 600 participants will receive either the experimental drug ivonescimab or the standard drug bevacizumab, both combined with chemotherapy. The goal…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
CBD tested as shield against Chemo's numbing side effect
Symptom relief Recruiting nowThis early-stage study is exploring whether taking CBD capsules can help prevent nerve damage (neuropathy) caused by a common chemotherapy drug called oxaliplatin. The trial will involve 30 people with colorectal cancer who are scheduled to receive oxaliplatin treatment. Particip…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: EARLY_PHASE1 • Sponsor: Fox Chase Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC